Simplex Trading
NVCR icon

Simplex Trading’s NovoCure NVCR Stock Holding History

Simplex Trading’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$314K Buy
28,800
+19,600
+213% +$245K ﹤0.01% 3782
2025
Q4 		$119K Sell
9,200
-26,800
-74% -$344K ﹤0.01% 4810
2025
Q3 		$465K Buy
36,000
+11,500
+47% +$154K ﹤0.01% 3920
2025
Q2 		$436K Buy
24,500
+16,300
+199% +$284K ﹤0.01% 3642
2025
Q1 		$146K Sell
8,200
-6,500
-44% -$148K ﹤0.01% 4647
2024
Q4 		$438K Buy
14,700
+5,500
+60% +$116K ﹤0.01% 3683
2024
Q3 		$143K Sell
9,200
-5,700
-38% -$103K ﹤0.01% 4864
2024
Q2 		$255K Sell
14,900
-46,700
-76% -$821K ﹤0.01% 4406
2024
Q1 		$962K Sell
61,600
-2,100
-3% -$30.9K ﹤0.01% 3164
2023
Q4 		$951K Sell
63,700
-10,600
-14% -$142K ﹤0.01% 3046
2023
Q3 		$1.2M Buy
74,300
+56,800
+325% +$1.64M ﹤0.01% 2501
2023
Q2 		$726K Sell
17,500
-70,100
-80% -$4.35M ﹤0.01% 2919
2023
Q1 		$5.27M Buy
87,600
+25,600
+41% +$2.05M ﹤0.01% 1268
2022
Q4 		$4.55M Buy
62,000
+25,500
+70% +$1.92M ﹤0.01% 1268
2022
Q3 		$2.77M Buy
36,500
+19,000
+109% +$1.48M ﹤0.01% 1687
2022
Q2 		$1.22M Sell
17,500
-27,900
-61% -$2.1M ﹤0.01% 2411
2022
Q1 		$3.76M Buy
45,400
+1,600
+4% +$118K ﹤0.01% 1493
2021
Q4 		$3.29M Buy
43,800
+33,100
+309% +$3.32M ﹤0.01% 1551
2021
Q3 		$2.03M Buy
10,700
+600
+6% +$90.7K ﹤0.01% 2118
2021
Q2 		$2.24M Buy
10,100
+10,038
+16,190% +$1.95M ﹤0.01% 2014
2021
Q1 		$819K Sell
62
-535
-90% -$84.6K ﹤0.01% 2663
2020
Q4 		$10.3M Sell
597
-232
-28% -$31.7K 0.01% 575
2020
Q3 		$9.23M Buy
829
+233
+39% +$18.6K 0.01% 540
2020
Q2 		$3.53M Sell
596
-582
-49% -$38.3K 0.01% 1076
2020
Q1 		$7.93M Buy
1,178
+430
+57% +$34K 0.01% 493
2019
Q4 		$6.3M Buy
748
+333
+80% +$26.9K 0.01% 664
2019
Q3 		$3.1M Buy
415
+245
+144% +$19.6K 0.01% 994
2019
Q2 		$1.07M Buy
170
+155
+1,033% +$7.85K ﹤0.01% 1829
2019
Q1 		$72K Sell
15
-62
-81% -$2.98K ﹤0.01% 4679
2018
Q4 		$257K Sell
77
-14
-15% -$512 ﹤0.01% 2883
2018
Q3 		$476K Buy
91
+90
+9,000% +$3.58K ﹤0.01% 2681
2018
Q2 		$3K Sell
1
-31
-97% -$862 ﹤0.01% 6936
2018
Q1 		$2K Sell
32
-18
-36% -$387 ﹤0.01% 5315
2017
Q4 		$4K Buy
50
+19
+61% +$366 ﹤0.01% 4716
2017
Q3 		$6K Sell
31
-91
-75% -$1.79K ﹤0.01% 4253
2017
Q2 		$9K Buy
+122
New +$1.57K ﹤0.01% 4075
2016
Q4 		– Sell
-234
Closed -$6K – 6313
2016
Q3 		$6K Buy
234
+134
+134% +$1.22K ﹤0.01% 4122
2016
Q2 		$39K Buy
100
+89
+809% +$1.11K ﹤0.01% 2292
2016
Q1 		$8K Buy
11
+1
+10% +$14 ﹤0.01% 3689
2015
Q4 		$1K Buy
+10
New +$239 ﹤0.01% 4940

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Simplex Trading's NVCR Position: Q1 2026 in Review

Simplex Trading increased its NovoCure (NVCR) stake by 115% in Q1 2026, buying an estimated $90.7K and bringing the position to 13,561 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #4649.

Simplex Trading first reported a position in NVCR in Q2 2016 and has held it in 30 quarters since. The position peaked at $2.38M in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Simplex Trading held 13,561 shares of NovoCure worth $148K as of Q1 2026.
  • Simplex Trading bought 7,260 NovoCure shares in Q1 2026, an estimated $90.7K.
  • NovoCure made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4649 holding.
  • Simplex Trading first reported a position in NovoCure in Q2 2016 and has held it in 30 quarters since.
  • Simplex Trading's NovoCure position peaked at $2.38M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.